| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | PD 166285 dihydrochloride |
|---|
| Description | Potent inhibitor of the tyrosine kinases c-Src, fibroblast growth factor receptor 1 (FGFR1), and platelet-derived growth factor receptor β (PDGFRβ) (IC50 values are 8.4, 39.3 and 98.3 nM respectively). Also inhibits the checkpoint kinases Wee1 and Myt1; abolishes Cdc2 phosphorylation in numerous tumor cell lines and abrogates the G2 checkpoint. Purity 99%. MW (observed): 585.35 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride |
|---|
| Gene, Accession, CAS # | CAS: 212391-63-4 |
|---|
| Catalog # | 3785/10 |
|---|
| Price | |
|---|
| Order / More Info | PD 166285 dihydrochloride from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 21795279 |
|---|
| 產(chǎn)品資料 |
|
|